Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gunton, J. E.
Right arrow Articles by McElduff, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gunton, J. E.
Right arrow Articles by McElduff, A.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 25:796-797, 2002
© 2002 by the American Diabetes Association, Inc.

Letters: Observations
Letters

Cigarette Smoking Affects Glycemic Control in Diabetes

Jenny E. Gunton, MBBS, FRACP, Linda Davies, BAPPSC, Errol Wilmshurst, MBBS, MRACP, MD, FRACP, Greg Fulcher, MBBS, MD, FRACP and Aidan McElduff, MBBS, PHD, FRACP

Department of Endocrinology, Royal North Shore Hospital, Sydney, Australia

Tight glycemic control in diabetes is one of the cornerstones of management. Glycemic control is usually assessed with HbA1c. The Diabetes Control and Complications Trial showed that in type 1 diabetes, decreasing HbA1c from 9.0 to 7.2% resulted in a 50–75% reduction in retinopathy, nephropathy, and neuropathy (1). The U.K. Prospective Diabetes Study (UKPDS) showed that in type 2 diabetes, decreasing HbA1c from 7.9 to 7.0% decreased retinopathy and nephropathy (2).

Increased insulin resistance occurs in smokers with and without diabetes (3,4). Smoking is also a risk factor for development of type 2 diabetes. The aim of this study was to determine whether smoking cessation was associated with improved glycemic control.

This study was a prospective cohort design and included 34 patients who ceased smoking, were followed for 1 year, and continued not to smoke at 1 year. Two control groups were randomly selected from patients participating in a prospective diabetes complications study (DCS). A DCS includes history, examination, ophthalmological review, and investigations, including HbA1c. The control groups were 34 never smokers and 34 current smokers. Smoking status was assigned based on patient self report. HbA1c was measured by high-performance liquid chromatography, with 3.5–5.7% as the normal range. Results are presented as means ± 1 SD. The study was approved by the institutional ethics committee.

Average consumption before cessation was 24 cigarettes per day. Mean age for the group who stopped smoking was 60 ± 15 years. A total of 7 subjects had type 1 diabetes, and 27 had type 2 diabetes. Mean HbA1c was 7.7 ± 2.2% while smoking and 7.0 ± 1.6% after smoking cessation (P = 0.048) (Fig. 1). Thus, the change in HbA1c was -0.70% (P < 0.0001 vs. expected change of 0%). Mean change was 0.07% for never smokers (P = 0.036) and 0.12% for continuing smokers (P < 0.01).



View larger version (28K):
[in this window]
[in a new window]
  		Figure 1— HbA1c before and after cessation of cigarette smoking in 34 patients.

 
Some studies have shown increased insulin resistance in association with cigarette smoking (3,4). It is possible that cigarette smoking may affect glycosylation of hemoglobin, although no studies were found with a literature search. It is possible that some patients may report smoking cessation when they continue to smoke. However, it seems unlikely that patients with diabetes would report continuing to smoke after stopping. Patients incorrectly reporting nonsmoking would tend to make the observed difference smaller than the true difference.

To our knowledge, this is the first study documenting improvement in HbA1c with smoking cessation. It may reflect a change in lifestyle factors, with the decision to stop smoking, or a direct effect. The 0.7% decrease is clinically significant, approaching the 0.9% in the UKPDS (2). The small but significant increases in other groups parallel the 0.12% rise per year in the UKPDS metformin group (2). These results constitute yet another reason why patients with diabetes should not smoke.

Footnotes

Address correspondence to Dr. Jenny Gunton, Department of Endocrinology, Royal North Shore Hospital, St. Leonards 2065, Australia. E-mail: jennyeg{at}hotmail.com.

References

  1. Diabetes Control and Complications Trial: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986, 1993[Abstract/Free Full Text]
  2. UK Prospective Diabetes Study: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853, 1998[Medline]
  3. Targher G, Alberiche M, Zenere MB, Bonadonna RC, Muggeo M, Bonora E: Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82:3619–3624, 1997[Abstract/Free Full Text]
  4. Ronnemaa T, Ronnemaa EM, Puukka P, Pyorala K, Laakso M: Smoking is independently associated with high plamsa insulin levels in nondiabetic men. Diabetes Care 19:1229–1232, 1996[Abstract]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Diabetes CareHome page
P. D. Terry, E. Weiderpass, C.-G. Ostenson, and S. Cnattingius
Cigarette Smoking and the Risk of Gestational and Pregestational Diabetes in Two Consecutive Pregnancies
Diabetes Care, November 1, 2003; 26(11): 2994 - 2998.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gunton, J. E.
Right arrow Articles by McElduff, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gunton, J. E.
Right arrow Articles by McElduff, A.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum